+ Translate
+ Most Popular
Advantages and disadvantages of bordeaux mixture and of lime-sulphur used on apples in the growing season
Observations on the Umaria marine bed
10 years of hearing conservation in the Royal Air Force
Chocolate crumb - dairy ingredient for milk chocolate
Effect of daily gelatin ingestion on human scalp hair
Comparison of rice bran and maize bran as feeds for growing and fattening pigs
The composition of pampas-grass (Cortaderia argentea.)
The Accraian Series:
The mechanism of the Liebermann-Burchard reaction of sterols and triterpenes and their esters
Cerebrovascular Doppler ultrasound studies (cv-Doppler)
Toria: PT-303 - first national variety
Hair growth promoting activity of tridax procumbens
Productivity of Pekin x Khaki Campbell ducks
A stable cytosolic expression of VH antibody fragment directed against PVY NIa protein in transgenic potato plant confers partial protection against the virus
Solar treatment of wheat loose smut
Swimmers itch in the Lake of Garda
Bactofugation and the Bactotherm process
The effects of prefrontal lobotomy on aggressive behavior in dogs
Visual rating scales for screening whorl-stage corn for resistance to fall armyworm
Breakdown of seamounts at the trench axis, viewed from gravity anomaly
Kooken; pennsylvania's toughest cave
Recovery of new dinosaur and other fossils from the Early Cretaceous Arundel Clay facies (Potomac Group) of central Maryland, U.S.A
Zubor horny (Bison bonasus) v prirodnych podmienkach Slovensku
The extended Widal test in the diagnosis of fevers due to Salmonella infection
Hair of the american mastodon indicates an adaptation to a semi aquatic habitat

Allopurinol and Loss of Consciousness in a 78-old Year Man Suffering from Gout

Allopurinol and Loss of Consciousness in a 78-old Year Man Suffering from Gout

Infectious Disorders Drug Targets 20(2): 253-256

ISSN/ISBN: 1871-5265

PMID: 30686265

Allopurinol is an FDA -Approved xanthine oxidase inhibitor, which is effective in the treatment of gout, hyperuricemia and uremic kidney stones in patients with an increased level of uric acid excretion. Xanthine oxidase acts by converting hypoxanthine and xanthine into uric acid, and therefore its inhibition results in decreased production of uric acid. The most common side effects of this medication are as follows: maculopapular rashes, hives, itching, headache, dizziness, abnormal hair loss, fever and hypersensitivity reaction. Case Presentation: This report represents a case of drug-induced meningitis of a senile man who ended up in the ICU due to the remarkably reduced state of consciousness.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 066127068

Download citation: RISBibTeXText

Related references

Desensitization to allopurinol after allopurinol hypersensitivity syndrome with renal involvement in gout. Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 6(5): 266-268, 2000

Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients. Clinical Rheumatology 26(9): 1459-1465, 2007

ACP Journal Club: allopurinol during acute gout attacks did not differ from delayed allopurinol for pain or recurrence. Annals of internal medicine 158(8): JC6, 2013

Treatment of gout with allopurinol and sulphinpyrazone in combination and with allopurinol alone. Annals of the Rheumatic Diseases 25(6 Suppl): 634-642, 1966

Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol. Annals of the Rheumatic Diseases 75(6): 1074-1080, 2016

More allopurinol is needed to get gout patients < 0.36 mmol/l: a gout audit in the form of a before-after trial. Journal of Primary Health Care 1(4): 315-318, 2009

Lesinurad combination therapy with allopurinol in gout: do CLEAR studies make the treatment of gout clearer?. Annals of the Rheumatic Diseases 77(7): E41, 2018

Lesinurad combination therapy with allopurinol in gout: do CLEAR studies make the treatment of gout clearer?. Annals of the Rheumatic Diseases 76(5): 779-781, 2017

Factors associated with acute gout attacks in normouricaemic gout patients receiving allopurinol: a retrospective study. Scandinavian Journal of Rheumatology 40(6): 444-447, 2011

ABCG2 gene polymorphism rs2231142 is associated with gout comorbidities but not allopurinol response in primary gout patients of a Chinese Han male population. Hereditas 156: 26, 2019

Preparative supercritical fluid chromatography for lipid class fractionation-a novel strategy in high-resolution mass spectrometry based lipidomics. Analytical and Bioanalytical Chemistry 412(10): 2365-2374, 2020

FRI0370 Efficacy and safety of lesinurad (RDEA594), a novel URAT1 inhibitor, in combination with allopurinol in allopurinol-refractory gout patients: Results from a randomized, blinded, placebo-controlled, phase 2b extension study. Annals of the Rheumatic Diseases 71(Suppl 3): 439-439, 2012

(Neurological CPC-59). A 65-year-old man with a history of gastric cancer who presented progressive loss of vision, memory loss and consciousness disturbance. No to Shinkei 49(11): 1041-1051, 1997

Fri0367Bcx4208 added to allopurinol increases response rates in patients with Gout who fail to reach goal range serum uric acid on allopurinol alone: A randomized, double-blind, placebo-controlled trial:. Annals of the Rheumatic Diseases 71(Suppl 3): 438.2-438, 2013

Effects of high protein and allopurinol supplemented diets on blood uric acid, ammonia concentration and xanthine dehydrogenase activity in liver and kidney in gout and non-gout lines. Bulletin of National Institute of Animal Industry 47: 37-42, 1988